Gene Expression Profile of Glioblastoma Peritumoral Tissue: An Ex Vivo Study

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Mangiola, Annunziato ^a   Saulnier, Nathalie ^a   De Bonis, Pasquale ^a   Orteschi, Daniela ^a   Sica, Gigliola ^a   Lama, Gina ^a   Pettorini, Benedetta Ludovica ^a   Sabatino, Giovanni ^a   Zollino, Marcella ^a   Lauriola, Libero ^a   Colabianchi, Anna ^a   Proietti, Gabriella ^a   Kovacs, Gyula ^b   Maira, Giulio ^a   Anile, Carmelo ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

NATURAL KILLER CELL LECTIN LIKE RECEPTOR SUBFAMILY C; TRANSCRIPTOME;

ARTICLE; BRAIN PERITUMORAL TISSUE; BRAIN TISSUE; CANCER GROWTH; CELL ADHESION; CELL INFILTRATION; CELL MOTILITY; CELL PROLIFERATION; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; DOWN REGULATION; EX VIVO STUDY; GENE EXPRESSION PROFILING; GENETIC ASSOCIATION; GENOMICS; GLIOBLASTOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; KLRC1 GENE; MOSAICISM; NERVOUS SYSTEM DEVELOPMENT; NUCLEOTIDE SEQUENCE; PRECANCER; TISSUE DISTRIBUTION; TISSUE MICROARRAY; TUMOR SUPPRESSOR GENE; UNINDEXED SEQUENCE; UPREGULATION; WHITE MATTER; BRAIN; BRAIN TUMOR; CELL MOTION; CLUSTER ANALYSIS; DNA MICROARRAY; GENE EXPRESSION REGULATION; GENETICS; GENOME-WIDE ASSOCIATION STUDY; METABOLISM; NERVE CELL; PATHOLOGY;

BRAIN; BRAIN NEOPLASMS; CELL ADHESION; CELL MOVEMENT; CELL PROLIFERATION; CLUSTER ANALYSIS; COMPARATIVE GENOMIC HYBRIDIZATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENOME-WIDE ASSOCIATION STUDY; GLIOBLASTOMA; HUMANS; NEURONS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; TRANSCRIPTOME;

EID: 84874620518     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0057145     Document Type: Article

References (45)

1. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, et al. (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352: 987-996.
2. Bai RY, Staedtke V, Riggins GJ, (2011) Molecular targeting of glioblastoma: Drug discovery and therapies. Trends Mol Med 17: 301-312.
3. Mangiola A, de Bonis P, Maira G, Balducci M, Sica G, et al. (2008) Invasive tumor cells and prognosis in a selected population of patients with glioblastoma multiforme. Cancer 113: 841-846.
4. Bakshi A, Nag TC, Wadhwa S, Mahapatra AK, Sarkar C, (1998) The expression of nitric oxide synthases in human brain tumours and peritumoral areas. J Neurol Sci 155: 196-203.
5. De Micheli E, Alfieri A, Pinna G, Bianchi L, Colivicchi MA, et al. (2000) Extracellular levels of taurine in tumoral, peritumoral and normal brain tissue in patients with malignant glioma: an intraoperative microdialysis study. Adv Exp Med Biol 483: 621-625.
6. Dehnhardt M, Zoriy MV, Khan Z, Reifenberger G, Ekstrom TJ, et al. (2008) Element distribution is altered in a zone surrounding human glioblastoma multiforme. J Trace Elem Med Biol 22: 17-23.
7. Stevenson CB, Ehtesham M, McMillan KM, Valadez JG, Edgeworth ML, et al. (2008) CXCR4 expression is elevated in glioblastoma multiforme and correlates with an increase in intensity and extent of peritumoral T2-weighted magnetic resonance imaging signal abnormalities. Neurosurgery 63: 560-569; discussion 569-570.
8. Nowacki P, Kojder I, (2001) Peritumoral angiogenesis around primary and metastatic brain neoplasms. Morphometric analysis. Folia Neuropathol 39: 95-102.
9. Lama G, Mangiola A, Anile C, Sabatino G, De Bonis P, et al. (2007) Activated ERK1/2 expression in glioblastoma multiforme and in peritumor tissue. Int J Oncol 30: 1333-1342.
10. Mangiola A, Lama G, Giannitelli C, De Bonis P, Anile C, et al. (2007) Stem cell marker nestin and c-Jun NH2-terminal kinases in tumor and peritumor areas of glioblastoma multiforme: possible prognostic implications. Clin Cancer Res 13: 6970-6977.
11. Sica G, Lama G, Anile C, Geloso MC, La Torre G, et al. (2011) Assessment of angiogenesis by CD105 and nestin expression in peritumor tissue of glioblastoma. Int J Oncol 38: 41-49.
12. Valli R, Maserati E, Marletta C, Pressato B, Lo Curto F, et al. (2011) Evaluating chromosomal mosaicism by array comparative genomic hybridization in hematological malignancies: the proposal of a formula. Cancer Genet 204: 216-218.
13. Chan SW, Lim CJ, Guo K, Ng CP, Lee I, et al. (2008) A role for TAZ in migration, invasion, and tumorigenesis of breast cancer cells. Cancer Res 68: 2592-2598.
14. Dahlback HS, Brandal P, Meling TR, Gorunova L, Scheie D, et al. (2009) Genomic aberrations in 80 cases of primary glioblastoma multiforme: Pathogenetic heterogeneity and putative cytogenetic pathways. Genes Chromosomes Cancer 48: 908-924.
15. Rao SK, Edwards J, Joshi AD, Siu IM, Riggins GJ, (2010) A survey of glioblastoma genomic amplifications and deletions. J Neurooncol 96: 169-179.
16. Hoi Sang U, Espiritu OD, Kelley PY, Klauber MR, Hatton JD, (1995) The role of the epidermal growth factor receptor in human gliomas: II. The control of glial process extension and the expression of glial fibrillary acidic protein. J Neurosurg 82: 847-857.
17. Wang H, Zhang W, Fuller GN, (2006) Overexpression of IGFBP5, but not IGFBP3, correlates with the histologic grade of human diffuse glioma: a tissue microarray and immunohistochemical study. Technol Cancer Res Treat 5: 195-199.
18. Tzeng SF, Bresnahan JC, Beattie MS, de Vellis J, (2001) Upregulation of the HLH Id gene family in neural progenitors and glial cells of the rat spinal cord following contusion injury. J Neurosci Res 66: 1161-1172.
19. Vandeputte DA, Troost D, Leenstra S, Ijlst-Keizers H, Ramkema M, et al. (2002) Expression and distribution of id helix-loop-helix proteins in human astrocytic tumors. Glia 38: 329-338.
20. Boon K, Edwards JB, Eberhart CG, Riggins GJ, (2004) Identification of astrocytoma associated genes including cell surface markers. BMC Cancer 4: 39.
21. Lee JH, Kim SH, Wang LH, Choi YL, Kim YC, et al. (2007) Clinical significance of CD99 down-regulation in gastric adenocarcinoma. Clin Cancer Res 13: 2584-2591.
22. Manara MC, Bernard G, Lollini PL, Nanni P, Zuntini M, et al. (2006) CD99 acts as an oncosuppressor in osteosarcoma. Mol Biol Cell 17: 1910-1921.
23. Scotlandi K, Zuntini M, Manara MC, Sciandra M, Rocchi A, et al. (2007) CD99 isoforms dictate opposite functions in tumour malignancy and metastases by activating or repressing c-Src kinase activity. Oncogene 26: 6604-6618.
24. Shih AH, Holland EC, (2006) Notch signaling enhances nestin expression in gliomas. Neoplasia 8: 1072-1082.
25. Zhou Z, Hao Y, Liu N, Raptis L, Tsao MS, et al. (2011) TAZ is a novel oncogene in non-small cell lung cancer. Oncogene 30: 2181-2186.
26. Bhat KP, Salazar KL, Balasubramaniyan V, Wani K, Heathcock L, et al. (2011) The transcriptional coactivator TAZ regulates mesenchymal differentiation in malignant glioma. Genes Dev 25: 2594-2609.
27. Kee HJ, Ahn KY, Choi KC, Won Song J, Heo T, et al. (2004) Expression of brain-specific angiogenesis inhibitor 3 (BAI3) in normal brain and implications for BAI3 in ischemia-induced brain angiogenesis and malignant glioma. FEBS Lett 569: 307-316.
28. Kohda T, Asai A, Kuroiwa Y, Kobayashi S, Aisaka K, et al. (2001) Tumour suppressor activity of human imprinted gene PEG3 in a glioma cell line. Genes Cells 6: 237-247.
29. Stefanova N, Schanda K, Klimaschewski L, Poewe W, Wenning GK, et al. (2003) Tumor necrosis factor-alpha-induced cell death in U373 cells overexpressing alpha-synuclein. J Neurosci Res 73: 334-340.
30. Burwinkel B, Shanmugam KS, Hemminki K, Meindl A, Schmutzler RK, et al. (2006) Transcription factor 7-like 2 (TCF7L2) variant is associated with familial breast cancer risk: a case-control study. BMC Cancer 6: 268.
31. Endo Y, Uzawa K, Mochida Y, Shiiba M, Bukawa H, et al. (2004) Sarcoendoplasmic reticulum Ca(2+) ATPase type 2 downregulated in human oral squamous cell carcinoma. Int J Cancer 110: 225-231.
32. Folsom AR, Pankow JS, Peacock JM, Bielinski SJ, Heiss G, et al. (2008) Variation in TCF7L2 and increased risk of colon cancer: the Atherosclerosis Risk in Communities (ARIC) Study. Diabetes Care 31: 905-909.
33. Kontani K, Chano T, Ozaki Y, Tezuka N, Sawai S, et al. (2003) RB1CC1 suppresses cell cycle progression through RB1 expression in human neoplastic cells. Int J Mol Med 12: 767-769.
34. Korosec B, Glavac D, Rott T, Ravnik-Glavac M, (2006) Alterations in the ATP2A2 gene in correlation with colon and lung cancer. Cancer Genet Cytogenet 171: 105-111.
35. Lal G, Padmanabha L, Smith BJ, Nicholson RM, Howe JR, et al. (2006) RIZ1 is epigenetically inactivated by promoter hypermethylation in thyroid carcinoma. Cancer 107: 2752-2759.
36. Chen PY, Chang WS, Chou RH, Lai YK, Lin SC, et al. (2007) Two non-homologous brain diseases-related genes, SERPINI1 and PDCD10, are tightly linked by an asymmetric bidirectional promoter in an evolutionarily conserved manner. BMC Mol Biol 8: 2.
37. Fatemi SH, Snow AV, Stary JM, Araghi-Niknam M, Reutiman TJ, et al. (2005) Reelin signaling is impaired in autism. Biol Psychiatry 57: 777-787.
38. Friedman JI, Vrijenhoek T, Markx S, Janssen IM, van der Vliet WA, et al. (2008) CNTNAP2 gene dosage variation is associated with schizophrenia and epilepsy. Mol Psychiatry 13: 261-266.
39. Mani M, Lee SY, Lucast L, Cremona O, Di Paolo G, et al. (2007) The dual phosphatase activity of synaptojanin1 is required for both efficient synaptic vesicle endocytosis and reavailability at nerve terminals. Neuron 56: 1004-1018.
40. McAvoy S, Ganapathiraju SC, Ducharme-Smith AL, Pritchett JR, Kosari F, et al. (2007) Non-random inactivation of large common fragile site genes in different cancers. Cytogenet Genome Res 118: 260-269.
41. Mittelbronn M, Simon P, Loffler C, Capper D, Bunz B, et al. (2007) Elevated HLA-E levels in human glioblastomas but not in grade I to III astrocytomas correlate with infiltrating CD8+ cells. J Neuroimmunol 189: 50-58.
42. Burger PC, Dubois PJ, Schold SC Jr, Smith KR Jr, Odom GL, et al. (1983) Computerized tomographic and pathologic studies of the untreated, quiescent, and recurrent glioblastoma multiforme. J Neurosurg 58: 159-169.
43. Donovan LK, Pilkington GJ, (2012) CD133: holy of grail of neuro-oncology or promiscuous red-herring? Cell Prolif 45: 527-537.
44. Mangiola A, Anile C, Pompucci A, Capone G, Rigante L, et al. (2010) Glioblastoma therapy: going beyond Hercules Columns. Expert Rev Neurother 10: 507-514.
45. Skog J, Wurdinger T, van Rijn S, Meijer DH, Gainche L, et al. (2008) Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat Cell Biol 10: 1470-1476.